Our company strives to maintain and improve every phase of our business and satisfy needs of our customers. All products at our site are available to be shipped - that means we have them in stock and can ship them to you within 3-5 business days after payment clearance.
Categories
Cilostazol
$0.57 USD
Cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance.
8.95$. Delivery period 14-21 days.
Free for orders more than $200.00 USD
27.95$. Delivery period 5-7 days.
Free for orders more than $300.00 USD
8.95$. Delivery period 14-21 days.Free for orders more than $200.00 USD
27.95$. Delivery period 5-7 days.Free for orders more than $300.00 USD
Cilostazol 100 mg
| Name | Quantity | Price Each | Total Price | Save | |
|---|---|---|---|---|---|
| Cilostazol 100 mg | 60 pills | $0.58 USD | $34.80 USD | ||
| Cilostazol 100 mg | 120 pills | $0.58 USD | $69.60 USD + Bonus - 6 pills | $0 USD | |
| Cilostazol 100 mg | 180 pills | $0.57 USD | $102.60 USD + Bonus - 6 pills | $1.80 USD | |
| Cilostazol 100 mg | 240 pills | $0.57 USD | $136.80 USD + Bonus - 12 pills | $2.40 USD | |
| Cilostazol 100 mg | 300 pills | $0.57 USD | $171.00 USD + Bonus - 12 pills | $3.00 USD | |
| Cilostazol 100 mg | 360 pills | $0.57 USD | $205.20 USD + Bonus - 12 pills Free AirMail Delivery | $3.60 USD |
- Product overview
Cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance.
Cilostazol Dosage and Administration
Recommended Dosage
The recommended dosage of Cilostazol is 100 mg twice daily taken at least half an hour before or two hours after breakfast and dinner.
Patients may respond as early as 2 to 4 weeks after the initiation of therapy, but treatment for up to 12 weeks may be needed before a beneficial effect is experienced. If symptoms are unimproved after 3 months, discontinue Cilostazol.
Dose Reduction with CYP3A4 and CYP2C19 Inhibitors
Reduce dose to 50 mg twice daily when co-administered with strong or moderate inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, erythromycin, and diltiazem) or inhibitors of CYP2C19 (e.g., ticlopidine, fluconazole, and omeprazole)
Dosage Forms and Strengths
Cilostazol Tablets USP are available as 50 mg and 100 mg round, white tablets. The 50 mg tablet is a flat faced beveled edge tablet, debossed with product identification “54 521” on one side and plain on the other side. The 100 mg tablet is a biconvex tablet, debossed with product identification “54 757” on one side and plain on the other side.
Contraindications
Cilostazol is contraindicated in patients with:
- •
- Heart failure of any severity: Cilostazol and several of its metabolites are inhibitors of phosphodiesterase III. Several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class III-IV heart failure.
Hypersensitivity to Cilostazol or any components of Cilostazol (e.g., anaphylaxis, angioedema).
Warnings and Precautions
Tachycardia
Cilostazol may induce tachycardia, palpitation, tachyarrhythmia or hypotension. The increase in heart rate associated with Cilostazol is approximately 5 to 7 bpm. Patients with a history of ischemic heart disease may be at risk for exacerbations of angina pectoris or myocardial infarction.
Hematologic Adverse Reactions
Cases of thrombocytopenia or leukopenia progressing to agranulocytosis when Cilostazol was not immediately discontinued have been reported. Agranulocytosis is reversible on discontinuation of Cilostazol. Monitor platelets and white blood cell counts periodically.
Hemostatic Disorders or Active Pathologic Bleeding
Cilostazol inhibits platelet aggregation in a reversible manner. Cilostazol has not been studied in patients with hemostatic disorders or active pathologic bleeding. Avoid use of Cilostazol in these patients.
